Englewood Lab Inc Cash Flow Conversion Efficiency
Englewood Lab Inc cash flow conversion efficiency. Based on the latest financial reports, Englewood Lab Inc (950140) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.76 Billion ≈ $4.58 Million USD) by net assets (₩154.89 Billion ≈ $104.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Englewood Lab Inc (2015–2024)
Cash flow conversion efficiency of Englewood Lab Inc from 2015 to 2024. This chart illustrates how Englewood Lab Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 950140 stock price and chart for real-time trading data and today's change.
Englewood Lab Inc Cash Flow Conversion Ratio Explained
Englewood Lab Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Englewood Lab Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Englewood Lab Inc ranked by their cash flow conversion efficiency. Also see Englewood Lab Inc (950140) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reworld Media
PA:ALREW
|
0.128x |
|
Nobleoak Life Ltd
AU:NOL
|
0.019x |
|
PT Surya Pertiwi Tbk
JK:SPTO
|
0.021x |
|
Eurofins-Cerep SA
PA:ALECR
|
-0.042x |
|
Medtecs International Corporation Ltd DRC
TW:9103
|
0.027x |
|
Shanghai Bailian Group Co Ltd B
SHG:900923
|
-0.046x |
|
Topower Co Ltd
TWO:3226
|
0.035x |
|
Apontis Pharma AG
XETRA:APPH
|
-0.061x |
Annual Cash Flow Conversion Efficiency for Englewood Lab Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Englewood Lab Inc from 2015 to 2024. Review Englewood Lab Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩97.89 Million ≈ $66.34K |
₩9.47 Million ≈ $6.42K |
0.097x | -46.14% |
| 2023-12-31 | ₩89.12 Million ≈ $60.40K |
₩16.01 Million ≈ $10.85K |
0.180x | -99.86% |
| 2022-12-31 | ₩73.41 Million ≈ $49.75K |
₩9.56 Billion ≈ $6.48 Million |
130.256x | +229.58% |
| 2021-12-31 | ₩68.28 Million ≈ $46.28K |
₩-6.86 Billion ≈ $-4.65 Million |
-100.526x | -176.80% |
| 2020-12-31 | ₩55.76 Million ≈ $37.79K |
₩7.30 Billion ≈ $4.95 Million |
130.892x | -42.97% |
| 2019-12-31 | ₩52.79 Million ≈ $35.78K |
₩12.12 Billion ≈ $8.21 Million |
229.494x | +224.24% |
| 2018-12-31 | ₩50.72 Million ≈ $34.37K |
₩-9.37 Billion ≈ $-6.35 Million |
-184.721x | -15.82% |
| 2017-12-31 | ₩56.31 Million ≈ $38.16K |
₩-8.98 Billion ≈ $-6.09 Million |
-159.487x | -340171.13% |
| 2016-12-31 | ₩61.90 Million ≈ $41.95K |
₩-2.90 Million ≈ $-1.97K |
-0.047x | -10.74% |
| 2015-12-31 | ₩26.65 Billion ≈ $18.06 Million |
₩-1.13 Billion ≈ $-764.48K |
-0.042x | -- |
About Englewood Lab Inc
Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; a… Read more